Search For "dcgi"
Glenmark responds to DCGI letter seeking clarification on Fabiflu
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] July 21 (ANI/PRNewswire): In response to the DCGI letter seeking clarification on FabiFlu, Glenmark Pharmaceuticals Ltd, a research-led, integrated global pharmaceutical company, has responded back. Please click the link below, to access the response letter.
Read More
COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir f
Updated : 5 years, 7 months ago IST
New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma giant- Jubilant Generics Ltd to manufacture and market the anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients, a senior health ministry offi
Read More
DCGI seeks clarification from Glenmark on its anti-viral favipiravir for u
Updated : 5 years, 7 months ago IST
New Delhi [India], July 19 (ANI): The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on COVID-19 patients with comorbidities.
Read More
FDA gives directions for using only ICMR-approved diagnostic kits in Goa
Updated : 5 years, 7 months ago IST
Panaji (Goa) [India], July 19 (ANI): Goa Food and Drugs Administration has urged people, chemists, and druggists that rapid diagnostic kits approved by the Indian Council of Medical Research and DCGI must be used.
Read More
Zydus gets Mexican regulator nod to conduct clinical trials with Pegylated
Updated : 5 years, 8 months ago IST
Ahmedabad (Gujarat) [India], July 17 (ANI): Pharmaceutical major Zydus said on Friday it has got approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) to conduct clinical trials with its biological therapy 'Pegylated Interferon alpha-2b' for the treatm
Read More
Ramesh Pokhriyal launches world's most affordable COVID-19 diagnostic kit
Updated : 5 years, 8 months ago IST
New Delhi [India], July 16 (ANI): Union Human Resource Development (HRD) Minister Ramesh Pokhriyal on Wednesday virtually launched the world's most affordable RT-PCR based COVID-19 diagnostic kit "Corosure" developed by IIT Delhi, and approved by the ICMR and DCGI.
Read More
Pharma giant Zydus Cadila initiates clinical study on 1,048 volunteers for
Updated : 5 years, 8 months ago IST
New Delhi [India], July 15 (ANI): Indian pharmaceutical giant Zydus Cadila has initiated the phase 1, 2 clinical trial to evaluate the safety and immunogenicity of coronavirus vaccine candidate by intradermal (injection) route in 1,048 subjects after the pharma company got approval from D
Read More
DCGI gives market approval for Pneumococcal Polysaccharide Conjugate Vacci
Updated : 5 years, 8 months ago IST
New Delhi [India], July 15 (ANI): The Drug Controller General of India (DCGI) has given approval to the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine.
Read More
Two indigenous candidate COVID-19 vaccines get DCGI nod to start early pha
Updated : 5 years, 8 months ago IST
New Delhi [India], July 14 (ANI): Two indigenous candidate vaccines for COVID-19 have got DCGI clearance to start early phase human trials in the country, the Indian Council of Medical Research (ICMR) said on Tuesday.
Read More
Biocon's drug Itolizumab gets DCGI nod for use in moderate to severe Covid
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], July 11 (ANI): Biopharmaceutical major Biocon Ltd said on Saturday it has received approval from the Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5ml solution for emergency use in India for the treatment of cytokine release syndr
Read More
DCGI approves Itolizumab injection for restricted emergency use on COVID-1
Updated : 5 years, 8 months ago IST
New Delhi [India], July 11 (ANI): The Drug Controller General of India (DCGI) granted its permission to Itolizumab injection for the restricted emergency use on COVID-19 patients with moderate to severe Acute Respiratory Distress Syndrome (ARDS) due to virus.
Read More
'No compromise on safety, security concerns': Govt on Aug 15 indigenous Co
Updated : 5 years, 8 months ago IST
New Delhi [India], July 9 (ANI): The Union Health Ministry on Thursday clarified that 15 August deadline for an indigenous Covid-19 vaccine is "only to expedite duly approved clinical trials without compromising on safety and security concerns".
Read More